(Q41393095)

30 September 2017

Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide (English)

1 reference

30 September 2017

B C Baguley

1

1 reference

PubMed ID

7781146

30 September 2017

L Zhuang

series ordinal

2

1 reference

PubMed ID

7781146

30 September 2017

E Marshall

series ordinal

3

1 reference

30 September 2017

1 January 1995

1 reference

Cancer Chemotherapy and Pharmacology

30 September 2017

1 reference

30 September 2017

36

1 reference

30 September 2017

244-248

1 reference

30 September 2017

3

1 reference

Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.

30 September 2017

1 reference

12 December 2020

DNA intercalating anti-tumour agents

1 reference

12 December 2020

Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.

1 reference

12 December 2020

DNA topoisomerase poisons as antitumor drugs

1 reference

12 December 2020

Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

1 reference

12 December 2020

Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells

1 reference

12 December 2020

Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single dose

1 reference

12 December 2020

Tumour profile of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouse.

1 reference

12 December 2020

Anticancer drug sensitivity profiles of new and established melanoma cell lines.

1 reference

12 December 2020

Unusual dynamics of killing of cultured Lewis lung cells by the DNA-intercalating antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

1 reference

12 December 2020

Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas

1 reference

12 December 2020

Microculture-Based Chemosensitivity Testing: A Feasibility Study Comparing Freshly Explanted Human Melanoma Cells With Human Melanoma Cell Lines

1 reference

12 December 2020

Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on colon 38 tumours in mice

1 reference

12 December 2020

Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice

1 reference

12 December 2020

Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs.

1 reference

12 December 2020

Pharmacokinetics and toxicity of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after i.v. administration in the mouse.

1 reference

12 December 2020

Resistance mechanisms to topoisomerase poisons: the application of cell culture methods

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002800050316

1 reference

30 September 2017

1 reference

PubMed ID

7781146